Following yesterday 15.63% move VRAL pulling back…Stock poised to explode.

Take a fresh look at our July 6, 2010 Profile Report!!!

“VRAL’s Compelling IP including Metabolic Disruption Technology could be transformational with potential applications in multiple disease fronts”

“If you have a strong risk tolerance and looking to build a position in this name this could be a $.20 by year end and as specific milestones along the road to commercialization with the ultimate goal of hitting the jackpot and having one of technologies licensed by a major Pharmaceutical company the stock has the potential to explode by 10-50 folds from current levels.”

July 6, 2010 Profile Report:

http://21webir.com/stocks-and-sectors/follow-up-profile-coverage-of-viral-genetics/

Please read our disclaimer carefully and do due diligence before you invest (see link below):

http://21webir.com/stocks-and-sectors/disclaimer-for-viral-genetics-vral-pink-sheet/